Menopausal vasomotor symptoms

In this episode we break down the pathophysiology and management of menopausal vasomotor symptoms, exploring the hypothalamic dysfunction driving hot flashes. We review primary hormone therapy guidelines, emphasizing individualized low-dose strategies. For patients seeking nonhormonal alternatives, we analyze the clinical roles of gabapentin, SSRIs, and novel neurokinin receptor antagonists like fezolinetant and elinzanetant. Finally, we discuss racial variations in symptom duration and how to implement shared decision-making to balance immediate relief with long-term patient safety.